Sacituzumab Govitecan in Recurrent Glioblastoma
NCT04559230
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Glioblastoma
Interventions
DRUG:
Sacituzumab Govitecan
Sponsor
The University of Texas Health Science Center at San Antonio